Table 4.
Change from baseline in vital signs over 12 weeks.
| UP1306 | Glucosamine and chondroitin combination | Placebo | p value | |
|---|---|---|---|---|
| Systolic BP mm Hg |
5.5 ± 13.3 (43) | 1.0 ± 16.2 (45) | −1.7 ± 14.0 (43) | 0.073# |
| 5 (−25–34) | 3 (−42–30) | −1 (−35–22) | ||
| p = 0.010∗ | p = 0.688 | p = 0.436 | ||
|
| ||||
| Diastolic BP mm Hg |
2.6 ± 7.9 (42) | 1.6 ± 8.7 (45) | −1.2 ± 7.1 (43) | 0.077# |
| 2.5 (−12–20) | 3 (−28–18) | −1 (−20–17) | ||
| p = 0.036∗ | p = 0.230 | p = 0.288 | ||
|
| ||||
| Heart rate beats/minute |
−1.2 ± 7.3 (43) | 1.3 ± 7.7 (45) | −1.3 ± 8.0 (43) | 0.205 |
| −1 (−26–12) | 1 (−15–18) | −1 (−18–14) | ||
| p = 0.304 | p = 0.277 | p = 0.273 | ||
∗Significant: p ≤ 0.05; #trending toward significance: p < 0.10, but p > 0.05.